RBC Capital Initiates Coverage On Guardant Health with Outperform Rating, Announces Price Target of $185

Benzinga Newsdesk www.benzinga.com Positive 62.3%

Neg 0% Neu 0% Pos 62.3%

RBC Capital analyst Dan Leonard initiates coverage on Guardant Health (NASDAQ:GH) with a Outperform rating and announces Price Target of $185.